SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
797Elusys Enters Into Infectious Disease License and Collaboration Agreement With Mnigel bates-4/20/2006
796Analysis: TGN1412 clouds superantibodies' future Steve Mitchell UPI Senior MIcebrg-4/14/2006
795BioInvent Interim Report 1 January - 31 March 2006 [2006-04-12 8:40] RecruitmenIcebrg-4/12/2006
794>>Sort of like maxy<< I sincerely hope they're more successful nigel bates-4/11/2006
793Thanks Nigel. I had a look at Domantis before. Coz it is in very early stages, pdr.praveen-4/11/2006
792<i>Domantis also has a strong Australian link through Peptech, a Sydney-banigel bates-4/11/2006
791Companies in Race to Develop a Simpler Approach Clive Cookson Press Date: Monddr.praveen-4/11/2006
790InNexus Biotechnology and Affimed Therapeutics AG to Collaborate Monday April 10nigel bates-4/10/2006
789Affitech Raises NOK 86 million ($ 13 million) in Private Placement Sunday April nigel bates-4/9/2006
788Affitech Renews Exclusive Worldwide Phage Display License From DKFZ Sunday Aprilnigel bates-4/9/2006
787Morphotek Announces Scientific Publications Describing Its Human Antibody Technonigel bates-4/3/2006
786PanGenetics BV Closes Series B Financing and Announces Board Appointments UTRECHnigel bates-3/27/2006
785Contamination is my first guess but perhaps this superMAB was more than humans nzeta1961-3/15/2006
784<I>Would be interesting to get 'Fred's' take on this...</i&nigel bates-3/15/2006
7836 hospitalised in PI debacle: Message 22260555 Statement re Clinical Volunteersnigel bates-3/15/2006
782Ablynx Reveals Power of Nanoclone - a High Throughput Method for Isolating Highldr.praveen-3/15/2006
781Plant-Made Pharmaceuticals Biopharming might be as easy as literally growing drIcebrg-3/9/2006
780Biosite and FivePrime Announce Antibody Collaboration Tuesday February 21, 8:00 nigel bates-2/21/2006
779Vaccinex, Inc Announces Antibody Collaboration With Schering AG ROCHESTER, N.Y.nigel bates-2/10/2006
778They say they are superior to existing mab's and also the new generation sindr.praveen-2/9/2006
777Interesting... phylogica.com Praveendr.praveen-2/9/2006
776Morphotek Issued U.S. Patent 6,982,169 Covering the Use of Chemical Inhibitors onigel bates-1/23/2006
775GlycoFi Announces the First Production of Antibodies with Human Glycosylation innigel bates-1/23/2006
774Ablynx Announces Pharma Alliance to Develop Therapeutic Nanobodies(TM) Wednesdaynigel bates-1/18/2006
773Drugs from Chimeric Chickens Origen Therapeutics, which raises chickens to lay Icebrg-1/16/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News